- Accepting New Patients
- Telehealth Visits
- Insurance plan information
Triveni Defries, MD, MPH
Internal Medicine- Accepting New Patients
- Telehealth Visits
- Insurance plan information
Liver Disease Parnassus
Triveni Defries, MD, MPH
Internal MedicineLiver Disease Parnassus
- Accepting New Patients
- Telehealth Visits
- Insurance plan information
On this page
Education & training
Board certification
- Addiction Medicine, American Board of Preventive Medicine
- Internal Medicine, American Board of Internal Medicine
Fellowship
- Addiction Medicine, University of CA at San Francisco School of Med
Residency
- Internal Medicine, University of CA at San Francisco School of Med
Degree
- MDD, UCSF School of Medicine
My expertise
Specialties
Locations
Component Name: Provider Research Listing component built but no clinical trials or publications to display
Clinical Trials query: q=health_gateway_id_ss%3A%28%222096%22%29+AND+status_s%3A%28%22Recruiting%22%29&rows=4&sort=date_published+desc&fq=content_type%3A%22Clinical+Trial%22
Puiblications query: q=health_gateway_id_ss%3A%28%222096%22%29&rows=4&sort=date_published+desc&fq=content_type%3A%22Publication%22
Please check with your health insurance plan regarding coverage for this type of care. Not all providers at UCSF Health are covered by every insurance plan.
For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here. The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.
For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here. The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.